Literature DB >> 21971558

Mesenchymal stem cell like (MSCl) cells generated from human embryonic stem cells support pluripotent cell growth.

Nóra Varga1, Zoltán Veréb, Eva Rajnavölgyi, Katalin Német, Ferenc Uher, Balázs Sarkadi, Agota Apáti.   

Abstract

Mesenchymal stem cell like (MSCl) cells were generated from human embryonic stem cells (hESC) through embryoid body formation, and isolated by adherence to plastic surface. MSCl cell lines could be propagated without changes in morphological or functional characteristics for more than 15 passages. These cells, as well as their fluorescent protein expressing stable derivatives, efficiently supported the growth of undifferentiated human embryonic stem cells as feeder cells. The MSCl cells did not express the embryonic (Oct4, Nanog, ABCG2, PODXL, or SSEA4), or hematopoietic (CD34, CD45, CD14, CD133, HLA-DR) stem cell markers, while were positive for the characteristic cell surface markers of MSCs (CD44, CD73, CD90, CD105). MSCl cells could be differentiated toward osteogenic, chondrogenic or adipogenic directions and exhibited significant inhibition of mitogen-activated lymphocyte proliferation, and thus presented immunosuppressive features. We suggest that cultured MSCl cells can properly model human MSCs and be applied as efficient feeders in hESC cultures.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971558     DOI: 10.1016/j.bbrc.2011.09.089

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  A hyaluronan hydrogel scaffold-based xeno-free culture system for ex vivo expansion of human corneal epithelial stem cells.

Authors:  D Chen; Y Qu; X Hua; L Zhang; Z Liu; S C Pflugfelder; D-Q Li
Journal:  Eye (Lond)       Date:  2017-02-17       Impact factor: 3.775

2.  Study of Bone Marrow and Embryonic Stem Cell-Derived Human Mesenchymal Stem Cells for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice.

Authors:  Qi Hao; Ying-Gang Zhu; Antoine Monsel; Stephane Gennai; Travis Lee; Fengyun Xu; Jae-Woo Lee
Journal:  Stem Cells Transl Med       Date:  2015-05-21       Impact factor: 6.940

3.  Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow.

Authors:  Patrick T Brown; Matthew W Squire; Wan-Ju Li
Journal:  Cell Tissue Res       Date:  2014-06-14       Impact factor: 5.249

4.  Chondrogenesis of Embryonic Stem Cell-Derived Mesenchymal Stem Cells Induced by TGFβ1 and BMP7 Through Increased TGFβ Receptor Expression and Endogenous TGFβ1 Production.

Authors:  Patrick T Lee; Wan-Ju Li
Journal:  J Cell Biochem       Date:  2016-06-21       Impact factor: 4.429

5.  Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor.

Authors:  Solvig Diederichs; Rocky S Tuan
Journal:  Stem Cells Dev       Date:  2014-04-28       Impact factor: 3.272

6.  Cultivation and characterization of cornea limbal epithelial stem cells on lens capsule in animal material-free medium.

Authors:  Réka Albert; Zoltán Veréb; Krisztián Csomós; Morten C Moe; Erik O Johnsen; Ole Kristoffer Olstad; Bjørn Nicolaissen; Eva Rajnavölgyi; László Fésüs; András Berta; Goran Petrovski
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  MSC-like cells increase ability of monocyte-derived dendritic cells to polarize IL-17-/IL-10-producing T cells via CTLA-4.

Authors:  Anett Mázló; Ramóna Kovács; Noémi Miltner; Márta Tóth; Zoltán Veréb; Krisztina Szabó; Ildikó Bacskai; Kitti Pázmándi; Ágota Apáti; Tamás Bíró; Krisztián Bene; Éva Rajnavölgyi; Attila Bácsi
Journal:  iScience       Date:  2021-03-15

8.  A Novel Cell-Based Model for a Rare Disease: The Tks4-KO Human Embryonic Stem Cell Line as a Frank-Ter Haar Syndrome Model System.

Authors:  Loretta László; Hédi Maczelka; Tamás Takács; Anita Kurilla; Álmos Tilajka; László Buday; Virag Vas; Ágota Apáti
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.